Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 247

1.

Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study.

Winter WE 3rd, Maxwell GL, Tian C, Sobel E, Rose GS, Thomas G, Carlson JW.

Gynecol Oncol. 2004 Aug;94(2):495-501.

PMID:
15297194
[PubMed - indexed for MEDLINE]
2.

Glucose as a prognostic factor in non-diabetic women with locally advanced cervical cancer (IIB-IVA).

Lee YY, Choi CH, Kim CJ, Song TJ, Kim MK, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS.

Gynecol Oncol. 2010 Mar;116(3):459-63. doi: 10.1016/j.ygyno.2009.11.016. Epub 2009 Dec 8.

PMID:
20004008
[PubMed - indexed for MEDLINE]
3.

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.

Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S.

N Engl J Med. 1999 Apr 15;340(15):1144-53. Erratum in: N Engl J Med 1999 Aug 26;341(9):708.

PMID:
10202165
[PubMed - indexed for MEDLINE]
Free Article
4.

Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer.

Novetsky AP, Einstein MH, Goldberg GL, Hailpern SM, Landau E, Fields AL, Mutyala S, Kalnicki S, Garg M.

Gynecol Oncol. 2007 Jun;105(3):635-40. Epub 2007 Feb 27.

PMID:
17331568
[PubMed - indexed for MEDLINE]
5.

Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.

Parker K, Gallop-Evans E, Hanna L, Adams M.

Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):140-6. doi: 10.1016/j.ijrobp.2008.06.1920. Epub 2008 Oct 14.

PMID:
18922646
[PubMed - indexed for MEDLINE]
6.

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix.

Grogan M, Thomas GM, Melamed I, Wong FL, Pearcey RG, Joseph PK, Portelance L, Crook J, Jones KD.

Cancer. 1999 Oct 15;86(8):1528-36.

PMID:
10526282
[PubMed - indexed for MEDLINE]
7.

Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors.

Schäfer U, Micke O, Müller SB, Schüller P, Willich N.

Strahlenther Onkol. 2003 Aug;179(8):527-34.

PMID:
14509951
[PubMed - indexed for MEDLINE]
8.

Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.

Rose PG, Ali S, Whitney CW, Lanciano R, Stehman FB.

Gynecol Oncol. 2011 Jun 1;121(3):542-5. doi: 10.1016/j.ygyno.2011.02.024. Epub 2011 Mar 21.

PMID:
21420157
[PubMed - indexed for MEDLINE]
9.

Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study.

Lavey RS, Liu PY, Greer BE, Robinson WR 3rd, Chang PC, Wynn RB, Conrad ME, Jiang C, Markman M, Alberts DS.

Gynecol Oncol. 2004 Oct;95(1):145-51.

PMID:
15385124
[PubMed - indexed for MEDLINE]
10.

Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects.

King M, McConkey C, Latief TN, Hartley A, Fernando I.

Clin Oncol (R Coll Radiol). 2006 Feb;18(1):38-45. Erratum in: Clin Oncol (R Coll Radiol). 2006 May;18(4):368.

PMID:
16477918
[PubMed - indexed for MEDLINE]
11.

Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.

Rose PG, Ali S, Watkins E, Thigpen JT, Deppe G, Clarke-Pearson DL, Insalaco S; Gynecologic Oncology Group.

J Clin Oncol. 2007 Jul 1;25(19):2804-10. Epub 2007 May 14.

PMID:
17502627
[PubMed - indexed for MEDLINE]
12.

Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.

Fuso L, Mazzola S, Marocco F, Ferrero A, Dompè D, Carus AP, Zola P.

Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S187-91. Epub 2005 Sep 26.

PMID:
16185756
[PubMed - indexed for MEDLINE]
13.

Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.

Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N, Weitmann H, Reinthaller A, Knocke TH, Wachter S, Kirisits C.

Radiother Oncol. 2007 May;83(2):148-55.

PMID:
17531904
[PubMed - indexed for MEDLINE]
14.

A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.

Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ.

Gynecol Oncol. 2009 Jan;112(1):85-9. doi: 10.1016/j.ygyno.2008.09.029. Epub 2008 Nov 1.

PMID:
18977518
[PubMed - indexed for MEDLINE]
15.

Retrospective analysis of concomitant Cisplatin during radiation in patients aged 55 years or older for treatment of advanced cervical cancer: a gynecologic oncology group study.

Kunos C, Tian C, Waggoner S, Rose PG, Lanciano R.

Int J Gynecol Cancer. 2009 Oct;19(7):1258-63. doi: 10.1111/IGC.0b013e3181b33ace.

PMID:
19823064
[PubMed - indexed for MEDLINE]
16.

Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group Study.

Moore DH, Tian C, Monk BJ, Long HJ, Omura GA, Bloss JD.

Gynecol Oncol. 2010 Jan;116(1):44-9. doi: 10.1016/j.ygyno.2009.09.006. Epub 2009 Oct 22.

PMID:
19853287
[PubMed - indexed for MEDLINE]
17.

Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study.

Atahan IL, Onal C, Ozyar E, Yiliz F, Selek U, Kose F.

Int J Gynecol Cancer. 2007 Jul-Aug;17(4):833-42. Epub 2007 Mar 15.

PMID:
17367320
[PubMed - indexed for MEDLINE]
18.

Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment.

Torres MA, Jhingran A, Thames HD Jr, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ.

Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):118-25. Epub 2007 Sep 14.

PMID:
17869451
[PubMed - indexed for MEDLINE]
19.

Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.

Chen SW, Liang JA, Hung YC, Yeh LS, Chang WC, Lin WC, Yang SN, Lin FJ.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1370-7. Epub 2006 Sep 18.

PMID:
16979836
[PubMed - indexed for MEDLINE]
20.

Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36.

PMID:
15380576
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk